Intas Pharmaceuticals Ltd. is a multinational pharmaceutical formulation development, manufacturing, and marketing company operating globally.
Subscribe to see Intas Pharmaceuticals Ltd.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
A few of Intas Pharmaceuticals Ltd.'s closest competitors — see the full list of competitors and alternatives →
Innova Captab Limited is a pharmaceutical company engaged in contract manufacturing, research, and the production of various pharmaceutical formulations.
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients (APIs), covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Lincoln Pharmaceuticals Limited develops and manufactures pharmaceutical formulations, medicines, and active pharmaceutical ingredients (APIs). Operating globally in over 60 countries, the company serves healthcare markets through domestic and international divisions.
InstaPill Private Limited is a pharmaceutical contract development and manufacturing organization (CDMO) specializing in advanced lyophilized orally disintegrating tablets (ODTs).
Indus Pharma is a pharmaceutical company headquartered in Pakistan that develops, manufactures, and markets branded generic healthcare products globally.
Ind-Swift Laboratories Limited is a leading pharmaceutical manufacturing company offering quality medicines, active pharmaceutical ingredients (APIs), formulations, and healthcare solutions. Headquartered in Chandigarh, India, it operates research and development facilities.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.